220 related articles for article (PubMed ID: 34403459)
21. The Phosphorylated Estrogen Receptor α (ER) Cistrome Identifies a Subset of Active Enhancers Enriched for Direct ER-DNA Binding and the Transcription Factor GRHL2.
Helzer KT; Szatkowski Ozers M; Meyer MB; Benkusky NA; Solodin N; Reese RM; Warren CL; Pike JW; Alarid ET
Mol Cell Biol; 2019 Feb; 39(3):. PubMed ID: 30455249
[TBL] [Abstract][Full Text] [Related]
22. DNA methylation at enhancers identifies distinct breast cancer lineages.
Fleischer T; Tekpli X; Mathelier A; Wang S; Nebdal D; Dhakal HP; Sahlberg KK; Schlichting E; ; Børresen-Dale AL; Borgen E; Naume B; Eskeland R; Frigessi A; Tost J; Hurtado A; Kristensen VN
Nat Commun; 2017 Nov; 8(1):1379. PubMed ID: 29123100
[TBL] [Abstract][Full Text] [Related]
23. Epigenetic and transcriptome responsiveness to ER modulation by tissue selective estrogen complexes in breast epithelial and breast cancer cells.
Messier TL; Boyd JR; Gordon JAR; Tye CE; Page NA; Toor RH; Zaidi SK; Komm BS; Frietze S; Stein JL; Lian JB; Stein GS
PLoS One; 2022; 17(7):e0271725. PubMed ID: 35862394
[TBL] [Abstract][Full Text] [Related]
24. Preclinical and clinical studies of estrogen deprivation support the PDGF/Abl pathway as a novel therapeutic target for overcoming endocrine resistance in breast cancer.
Weigel MT; Ghazoui Z; Dunbier A; Pancholi S; Dowsett M; Martin LA
Breast Cancer Res; 2012 May; 14(3):R78. PubMed ID: 22608253
[TBL] [Abstract][Full Text] [Related]
25. 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells.
Swami S; Krishnan AV; Feldman D
Clin Cancer Res; 2000 Aug; 6(8):3371-9. PubMed ID: 10955825
[TBL] [Abstract][Full Text] [Related]
26. Release of methyl CpG binding proteins and histone deacetylase 1 from the Estrogen receptor alpha (ER) promoter upon reactivation in ER-negative human breast cancer cells.
Sharma D; Blum J; Yang X; Beaulieu N; Macleod AR; Davidson NE
Mol Endocrinol; 2005 Jul; 19(7):1740-51. PubMed ID: 15746193
[TBL] [Abstract][Full Text] [Related]
27. Nuclear-encoded mitochondrial MTO1 and MRPL41 are regulated in an opposite epigenetic mode based on estrogen receptor status in breast cancer.
Kim TW; Kim B; Kim JH; Kang S; Park SB; Jeong G; Kang HS; Kim SJ
BMC Cancer; 2013 Oct; 13():502. PubMed ID: 24160266
[TBL] [Abstract][Full Text] [Related]
28. Global identification of genes regulated by estrogen signaling and demethylation in MCF-7 breast cancer cells.
Putnik M; Zhao C; Gustafsson JÅ; Dahlman-Wright K
Biochem Biophys Res Commun; 2012 Sep; 426(1):26-32. PubMed ID: 22902638
[TBL] [Abstract][Full Text] [Related]
29. Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine-resistant breast cancer.
Achinger-Kawecka J; Valdes-Mora F; Luu PL; Giles KA; Caldon CE; Qu W; Nair S; Soto S; Locke WJ; Yeo-Teh NS; Gould CM; Du Q; Smith GC; Ramos IR; Fernandez KF; Hoon DS; Gee JMW; Stirzaker C; Clark SJ
Nat Commun; 2020 Jan; 11(1):320. PubMed ID: 31949157
[TBL] [Abstract][Full Text] [Related]
30. Estrogen receptor alpha-mediated silencing of caveolin gene expression in neuronal cells.
Zschocke J; Manthey D; Bayatti N; van der Burg B; Goodenough S; Behl C
J Biol Chem; 2002 Oct; 277(41):38772-80. PubMed ID: 12138116
[TBL] [Abstract][Full Text] [Related]
31. Reconfiguration of nucleosome-depleted regions at distal regulatory elements accompanies DNA methylation of enhancers and insulators in cancer.
Taberlay PC; Statham AL; Kelly TK; Clark SJ; Jones PA
Genome Res; 2014 Sep; 24(9):1421-32. PubMed ID: 24916973
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of potential implication of membrane estrogen binding sites on ERE-dependent transcriptional activity and intracellular estrogen receptor-alpha regulation in MCF-7 breast cancer cells.
Seo HS; Leclercq G
J Steroid Biochem Mol Biol; 2002 Jan; 80(1):109-23. PubMed ID: 11867270
[TBL] [Abstract][Full Text] [Related]
33. Loss of TET2 in hematopoietic cells leads to DNA hypermethylation of active enhancers and induction of leukemogenesis.
Rasmussen KD; Jia G; Johansen JV; Pedersen MT; Rapin N; Bagger FO; Porse BT; Bernard OA; Christensen J; Helin K
Genes Dev; 2015 May; 29(9):910-22. PubMed ID: 25886910
[TBL] [Abstract][Full Text] [Related]
34. Estradiol-Induced Epigenetically Mediated Mechanisms and Regulation of Gene Expression.
Kovács T; Szabó-Meleg E; Ábrahám IM
Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32365920
[TBL] [Abstract][Full Text] [Related]
35. Genome-wide analysis of aberrant methylation of enhancer DNA in human osteoarthritis.
Lin X; Li L; Liu X; Tian J; Zheng W; Li J; Wang L
BMC Med Genomics; 2020 Jan; 13(1):1. PubMed ID: 31900157
[TBL] [Abstract][Full Text] [Related]
36. DNA methylome-wide alterations associated with estrogen receptor-dependent effects of bisphenols in breast cancer.
Awada Z; Nasr R; Akika R; Cahais V; Cuenin C; Zhivagui M; Herceg Z; Ghantous A; Zgheib NK
Clin Epigenetics; 2019 Oct; 11(1):138. PubMed ID: 31601247
[TBL] [Abstract][Full Text] [Related]
37. TET2 binding to enhancers facilitates transcription factor recruitment in hematopoietic cells.
Rasmussen KD; Berest I; Keβler S; Nishimura K; Simón-Carrasco L; Vassiliou GS; Pedersen MT; Christensen J; Zaugg JB; Helin K
Genome Res; 2019 Apr; 29(4):564-575. PubMed ID: 30796038
[TBL] [Abstract][Full Text] [Related]
38. Estrogen receptor and HER2/neu status affect epigenetic differences of tumor-related genes in primary breast tumors.
Sunami E; Shinozaki M; Sim MS; Nguyen SL; Vu AT; Giuliano AE; Hoon DS
Breast Cancer Res; 2008; 10(3):R46. PubMed ID: 18485221
[TBL] [Abstract][Full Text] [Related]
39. The histone variant H2A.Z is an important regulator of enhancer activity.
Brunelle M; Nordell Markovits A; Rodrigue S; Lupien M; Jacques PÉ; Gévry N
Nucleic Acids Res; 2015 Nov; 43(20):9742-56. PubMed ID: 26319018
[TBL] [Abstract][Full Text] [Related]
40. Whole-epigenome analysis in multiple myeloma reveals DNA hypermethylation of B cell-specific enhancers.
Agirre X; Castellano G; Pascual M; Heath S; Kulis M; Segura V; Bergmann A; Esteve A; Merkel A; Raineri E; Agueda L; Blanc J; Richardson D; Clarke L; Datta A; Russiñol N; Queirós AC; Beekman R; Rodríguez-Madoz JR; San José-Enériz E; Fang F; Gutiérrez NC; García-Verdugo JM; Robson MI; Schirmer EC; Guruceaga E; Martens JH; Gut M; Calasanz MJ; Flicek P; Siebert R; Campo E; Miguel JF; Melnick A; Stunnenberg HG; Gut IG; Prosper F; Martín-Subero JI
Genome Res; 2015 Apr; 25(4):478-87. PubMed ID: 25644835
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
